. 2015 Jan 21;12:2. doi: 10.1186/s12970-014-0063-6

Table 2.

Perceived muscle soreness of the right leg

Variable	Group	Pre DHR (day 0)	POST (day 0)	24 hr post	48 hr post	72 hr post
Gastrocnemius	MIPS (n = 9)	15.7 ± 20.7	18.3 ± 19.8	17.7 ± 21.4	12.8 ± 21.1^c	13.1 ± 17.4^c
Gastrocnemius	CON (n = 10)	9.3 ± 9.7	10.6 ± 10.6	16.1 ± 13.1	11.4 ± 9.7^c	13.0 ± 14.9^c
Rectus Femoris*	MIPS (n = 9)	11.2 ± 18.5	14.7 ± 14.5	19.4 ± 15.0^abde	14.7 ± 15.5^e	8.5 ± 10.1^b
Rectus Femoris*	CON (n = 10)	10.3 ± 9.0	14.7 ± 9.6	26.1 ± 18.0^abde	15.8 ± 14.6^e	13.5 ± 11.1^b
Vastus Lateralis*	MIPS (n = 8)	6.6 ± 10.6	16.0 ± 15.3^a	21.8 ± 19.6^ab	17.2 ± 17.3^a	16.7 ± 21.2^a
Vastus Lateralis*	CON (n = 10)	8.2 ± 5.8	14.0 ± 11.2^a	19.9 ± 15.6^ab	19.4 ± 15.7^a	11.1 ± 7.9^a
Vastus Medialis*	MIPS (n = 8)	11.0 ± 14.3	24.6 ± 19.7^a	34.3 ± 24.8^abde	20.7 ± 24.8	16.6 ± 20.9
Vastus Medialis*	CON (n = 10)	12.6 ± 10.0	16.6 ± 12.3^a	26.5 ± 21.0^abde	21.4 ± 16.9	17.0 ± 13.8
Biceps Femoris*	MIPS (n = 9)	7.3 ± 12.8	9.45 ± 11.7^a	21.5 ± 17.5^abe	11.7 ± 17.8^a	12.1 ± 14.6^a
Biceps Femoris*	CON (n = 10)	5.0 ± 4.0	10.2 ± 9.4^a	19.2 ± 18.9^abe	13.3 ± 12.0^a	7.9 ± 9.8^a
Gluteus Maximus*	MIPS (n = 9)	6.5 ± 10.2	13.6 ± 16.9^a	20.2 ± 21.3^a	13.2 ± 19.3^a	8.5 ± 14.5
Gluteus Maximus*	CON (n = 10)	6.3 ± 6.5	9.0 ± 8.6^a	10.8 ± 11.7^a	6.6 ± 6.7^a	8.2 ± 7.7
Mean Muscle Soreness*	MIPS (n = 7)	66.3 ± 88.1	110.9 ± 97.1^a	153.3 ± 104.4^abde	105.9 ± 106.6^a	88.6 ± 100.6
Mean Muscle Soreness*	CON (n = 8)	55.3 ± 40.3	74.1 ± 58.6^a	114.6 ± 90.5^abde	86.6 ± 73.3^a	74.4 ± 63.2

Values are expressed as mean ± SD. MIPS: Multi-Ingredient Performance Supplement; CON: Control Carbohydrate Placebo.

*p < 0.05, significant time effect.

^a p < 0.05, significantly different from Pre.

^b p < 0.05, significantly from POST.

^c p < 0.05, significantly different from 24 hr.

^d p < 0.05, significantly from 48 hr.

^e p < 0.05, significantly different from 72 hr.